The Long, Controversial Search for a ‘Cancer Microbiome’May 6, 2024Patient & Survivor CarePediatricsDLBCLAggressive LymphomasALLAMLB Cell Lymphoma
Few Cancer Survivors Meet ACS Nutrition, Exercise GuidelinesApril 26, 2024Patient & Survivor CareDLBCLAggressive LymphomasALLAMLB Cell LymphomaCLL
Most Targeted Cancer Drugs Lack Substantial Clinical BenefitApril 17, 2024DLBCLGene TherapyPatient & Survivor CarePediatricsMixed TopicsBusiness of MedicineALL
No Routine Cancer Screening Option? New MCED Tests May HelpApril 15, 2024Patient & Survivor CareDLBCLAggressive LymphomasALLAMLB Cell LymphomaCLL
Oncologists Voice Ethical Concerns Over AI in Cancer CareApril 12, 2024DLBCLPatient & Survivor CarePediatricsMixed TopicsALLAggressive LymphomasB Cell Lymphoma
Less Than 50% of Accelerated Approvals Show Clinical BenefitApril 9, 2024DLBCLMixed TopicsPatient & Survivor CareAggressive LymphomasALLAMLB Cell Lymphoma
Abecma Approved for Earlier Lines in Relapsed/Refractory Multiple MyelomaApril 9, 2024Multiple MyelomaCellular Therapy
Virtual Reality Brings Relief to Hospitalized Patients With CancerApril 8, 2024Patient & Survivor CareDLBCLPediatricsALLAggressive LymphomasAMLB Cell Lymphoma
Should Opioids Be Used for Chronic Cancer Pain?April 5, 2024Patient & Survivor CareOpioid Resource CenterFast Facts FridayDLBCLMixed TopicsAggressive LymphomasALL
A Banned Chemical That Is Still Causing CancerApril 3, 2024DLBCLPatient & Survivor CareMixed TopicsBusiness of MedicineAggressive LymphomasALLAML
Active Surveillance for Cancer Doesn’t Increase Malpractice RiskApril 1, 2024Patient & Survivor CareAggressive LymphomasALLAMLB Cell LymphomaCLLCML
ASCO Releases Vaccination Guidelines for Adults With CancerMarch 28, 2024ASCO Breast CancerASCO Lung CancerMultiple MyelomaMyelodysplastic Syndrome
